CD8A and neoplasm: Analysis of spleen cells demonstrated the induction of CD8+ T cell responses against KSL9, one of the four candidate neoantigens, in mice that prevented tumor growth, suggesting tumor rejection mediated by KSL9-reactive T cells (Fig. 6B).